Advanced search
Publication Cover
Expert Opinion on Investigational Drugs Volume 24, 2015 - Issue 2
Submit an article Journal homepage
43
Views
2
CrossRef citations to date
0
Altmetric
Further Readings

Related articles

Page 1 | Published online: 12 Jan 2015

Citations (2)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Viviana Lacava, Vincenzo Pellicanò, Carmen Ferrajolo, Valeria Cernaro, Luca Visconti, Giovanni Conti, Michele Buemi & Domenico Santoro. (2017) Novel avenues for treating diabetic nephropathy: new investigational drugs. Expert Opinion on Investigational Drugs 26:4, pages 445-462.
Read now

Articles from other publishers (1)

Shubham Atal, Zeenat Fatima, Sakshi Singh, Sadasivam Balakrishnan & Rajnish Joshi. (2020) Remogliflozin: the new low cost SGLT-2 inhibitor for type 2 diabetes mellitus. Diabetology International 12:3, pages 247-253.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.